HCA Healthcare (HCA) FY2019 results: revenue $51.3 billion, up 10.0% on the year
HCA Healthcare, Inc. (HCA) reported revenue of $51.3 billion for fiscal 2019, the year ended 31 December 2019, up 10.0% on the year before. Net income was $3.5 billion, down 7.4%, and diluted earnings per share $10.07. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2022.
Revenue
$51.3 billion
+10.0% on the year
FY2016FY2019
Operating margin
10.2%
11.4% a year earlier
FY2016FY2019
Net income
$3.5 billion
-7.4% on the year
FY2016FY2019
Diluted EPS
$10.07
-5.5% on the year
FY2016FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
51,336
46,677
43,614
+10.0%
Operating income
5,244
5,335
4,381
-1.7%
Operating margin
10.2%
11.4%
10.0%
Interest expense
1,824
1,755
1,690
+3.9%
Pre-tax income
5,244
5,335
4,381
-1.7%
Income tax
1,099
946
1,638
+16.2%
Effective tax rate
21.0%
17.7%
37.4%
Net income
3,505
3,787
2,216
-7.4%
Net margin
6.8%
8.1%
5.1%
Diluted EPS
$10.07
$10.66
$5.95
-5.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
7,602
6,761
5,426
+12.4%
Capital expenditure
4,158
3,573
3,015
+16.4%
Free cash flow
3,444
3,188
2,411
+8.0%
Free cash flow margin
6.7%
6.8%
5.5%
Cash from investing
-5,720
-3,901
-4,279
Cash from financing
-1,771
-3,075
-1,061
Depreciation and amortisation
2,596
2,278
2,131
+14.0%
Share-based compensation
347
268
270
+29.5%
Buybacks
1,031
1,530
2,051
-32.6%
Dividends paid
550
487
0.0
+12.9%
Dividend per share
$1.60
$1.40
n/a
+14.3%
Diluted shares, weighted
348m
355m
372m
-2.0%
Shares outstanding at period end
338m
343m
350m
-1.3%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
-2,808
-4,950
-6,806
Non-controlling interest
2,243
2,032
1,811
+10.4%
Debt
33,722
32,821
33,058
+2.7%
Operating lease liabilities
1,499
n/a
n/a
Finance lease liabilities
470
n/a
n/a
Other liabilities
9,932
9,304
8,530
+6.7%
Total liabilities and equity
45,058
39,207
36,593
+14.9%
Fixed assets
22,715
19,757
17,895
+15.0%
Investments
462
409
472
+13.0%
Cash and equivalents
621
502
732
+23.7%
Receivables
7,380
6,789
6,501
+8.7%
Inventory
1,849
1,732
1,573
+6.8%
Other assets
12,031
10,018
9,420
+20.1%
Total assets
45,058
39,207
36,593
+14.9%
10-K for the year ended 31 December 2019, filed 18 February 2022: the filing.